Introduction
Schizophrenia is a complex disorder in which both genetic and environmental factors are involved. Multiple linkage studies have implicated chromosome 5q21-33 as a region likely to harbor risk genes, 1, 2 including the study of Irish Study of High Density Schizophrenia Families (ISHDSF). 2, 3 For the last few years, significant progress has been made in the field, such as the identification of the dysbindin gene in 6p, 4 the neuregulin gene in 1 in 8p 5 and the TRACE4 gene in 10p. 6 We started fine-mapping of the 5q22-31 linkage peak in the ISHDSF several years ago and found a broad region showing consistent associations with schizophrenia. This region covers several genes and spans about one million base pairs of genomic sequence. One of the genes showing associations is ACSL6 (acyl-CoA synthetase long-chain member 6).
Immediately telomeric to the ACSL6 gene is interleukin 3 (IL3) gene. The ACSL6 and IL3 genes are arranged in a head-to-head orientation, sharing a potential regulatory region of about 46 kb. In our finemapping, some single nucleotide polymorphisms (SNPs) in this 46 kb interval showed signs of association. From the literature, multiple regulatory elements, including 4 estrogen response elements (EREs), have been identified in this 46 kb interval. 7, 8 In an effort to define the boundary of association signals for the ACSL6 gene, we extended our search to include this 46 kb regulatory region and IL3 gene, hoping to exclude IL3 from the list of genes associated with the disease in our broad linkage region. To our surprise, we found that several SNPs in the wellstudied and well-defined IL3 promoter and enhancer were associated with schizophrenia. These potentially functional associations in IL3 promoter and enhancer prompted us to study more carefully of the IL3 gene and its involvement in schizophrenia. For this reason, we used two more independent samples to verify the results obtained in our fine-mapping sample. In this article, we report the evidence of sex-specific, family-history-dependent association in this promoter region and its potential connection to the IL3 gene.
IL3 is one of the cytokines that has multiple biological functions. 9 In addition to its roles in hematopoiesis, IL3 is involved in neural development. [10] [11] [12] Of particular interest is that IL3 can stimulate cell growth and suppress apoptosis. 13 Dysfunction of apoptosis may be involved in the pathophysiology of schizophrenia.
14 Abnormal activities of several interleukins, 15, 16 including IL3, 17 have been observed in schizophrenia patients. All these lines of evidence suggest that IL3 is a plausible functional candidate for schizophrenia.
Materials and methods
The ISHDSF sample The ISHDSF was collected in Northern Ireland, United Kingdom and the Republic of Ireland. Phenotypes were assessed using estrogen response element (DSM)-III-R. The diagnoses were formed into a hierarchy of 10 categories reflecting the probable genetic relationship of these syndromes to classic schizophrenia. This hierarchy consisted of three definitions of affection: (i) narrow -categories D1 and D2, or 'core schizophrenia' -schizophrenia, pooroutcome schizoaffective disorder and simple schizophrenia; (ii) intermediate -categories D1-D5, or a narrow definition of the schizophrenia spectrum, adding to the narrow definition schizotypal personality disorder, schizophreniform disorder, delusional disorder, atypical psychosis and good-outcome schizoaffective disorder; (iii) broad -categories D1-D8, including all disorders that significantly aggregated in relatives of schizophrenic probands in the Roscommon Family Study 18 and adding to the intermediate definition mood incongruent and mood congruent psychotic affective illness, and paranoid, avoidant and schizoid personality disorder. The final inclusion criteria for pedigrees in the ISHDSF sample required two or more first, second or third-degree relatives with a diagnosis of D1-D5, one or more of whom had a D1-D2 diagnosis. The sample contained 273 pedigrees and about 1350 subjects had DNA sample for genotyping. Of them, 515 were diagnosed with the narrow definition (351 males and 164 females), 634 were diagnosed with the intermediate definition and 686 were diagnosed with the broad definition. Detail descriptions of the sample were published previously. 19 The Irish Case-Control Study of Schizophrenia sample The Irish Case-Control Study of Schizophrenia (ICCSS) sample was collected in the same geographic regions as that of the ISHDSF sample. In this study, we used a subset of 657 affected subjects (436 males and 221 females) and 411 controls (233 males and 178 females) from this study. The affected subjects were selected from in-patient and out-patient psychiatric facilities in the Republic of Ireland and Northern Ireland. Subjects were eligible for inclusion if they had a diagnosis of schizophrenia or poor-outcome schizoaffective disorder by DSM-III-R criteria, which was confirmed by a blind expert diagnostic review. Controls, selected from several sources, including blood donation centers, were included if they denied a lifetime history of schizophrenia. Both cases and controls were included only if they reported all four grandparents as being born in Ireland or the United Kingdom. Family history (FH), based on the familyhistory research diagnostic criteria, 20 was assessed by clinical interview of probands and their relatives. Subjects having a first or second-degree relative diagnosed with schizophrenia were classified as FH positive. In the ICCSS sample, there were 117 subjects (71 males and 46 females) classified with positive FH of schizophrenia.
The Irish Trio Study of Schizophrenia sample
The Irish trios (Irish Trio Study of Schizophrenia (ITRIO)) were collected in the same period as the ICCSS sample and the inclusion criteria and symptom ascertainments were the same as that of ICCSS sample. The only difference was that for the trios, both parents of the proband were included. In ITRIO, there were 187 families. Of these families, 26 families had two affected subjects, and two families had three affected subjects, the remainder having a single affected subject. In addition, there were 29 subjects who had another first or second-degree relative diagnosed of schizophrenia. The total number of probands with positive FH was therefore 87 (57 families, 65 males, 22 females).
Marker selection and genotyping
We used the HapMap data and the available assays developed by Applied BioSystems (Foster City, CA, USA) to assist our selection of markers. We elected to use SNPs that tag major haplotypes (with frequency > 1%) in the region. Rs3846726 and rs3916441 were included to give even spacing of markers. We found a non-synonymous SNP (rs40401) in the IL3 gene, so we included it as well. Of the 12 markers used, three (rs399714, rs77938 and 440970) were in the ACSL6 gene, five (rs246999, rs3914025, rs3846726, rs3916441 and rs31400) were located between the coding sequences of ACSL6 and IL3, and four (rs31480, rs40401, rs31481 and rs2069803) were in the IL3 gene (Figure 1a) .
We used two techniques for SNP genotyping. A majority of SNPs were typed by the TaqMan assay. 21 SNPs typed by this method were either validated assays or custom-designed assays developed by Applied BioSystems Incorporated (Foster City, CA, USA). We also used the FP-TDI protocol 22, 23 to type some SNPs. For the FP-TDI procedures, DNA sequences of SNPs obtained from dbSNP (http://www.ncbi.nlm.nih.gov/SNP/index.html) were masked by the RepeatMasker program 24 and polymerase chain reaction (PCR) and template-directed dye incorporation assay with fluorescence polarization detection (FP-TDI) extension primers were designed by the PRIMER 3 program. We used the FP-TDI genotyping products from the Perkin Elmer Corporation (Boston, MA, USA) and followed the recommended procedures for PCR and single base extension. All markers typed were checked for deviation from the Hardy-Weinberg equilibrium (HWE) and Mendelian errors by the PEDSTATS program. 25 
Statistical analyses
We used the pedigree disequilibrium test (PDT) 26 as implemented in the UNPHASED 27 program (PDTPHASE module) to analyze the ISHDSF sample. For each typed SNP, the PDT program was run for the narrow, intermediate and broad disease definitions. In these analyses, both vertical and horizontal transmissions were included. The P-values reported were based on weighing all families equally (the ave option in the program). In multilocus haplotype analyses, we used 10 restarts for the expectation-maximization algorithm 28 and used 1% as the cutoff for minor haplotypes. For the case-control sample, w 2 tests were performed for each SNP for allelic associations. For haplotype analyses, the COCAPHASE module of the UNPHASED program 27 was used to analyze multimarker haplotype associations. As in the family sample, haplotypes with frequencies less than 1% were aggregated. For all tests, global and individual haplotype tests were performed simultaneously and P-values obtained were w 2 distributions. For the ITRIO, we used TDTPHASE module of the UN-PHASED program as there were no unaffected sibling in the families. The P-values reported for the ISHDSF sample were obtained with permutations (1000 permutations for the individual markers and 5000 permutations for multi-marker haplotype analyses) and those for the ICCSS and ITRIO samples were uncorrected. We report the permutated P-values for the ISHDSF because almost all markers used in this study had strong linkage disequilibrium (LD) with each other (see Figure 1b) and all phenotypes tested were hierarchically organized, that is, the broad disease definition included the intermediate and the narrow definitions, and the intermediate definition included the narrow definition. In sex-conditioned analyses, only male or female subjects (ICCSS) or affected offspring (ISHDSF and ITRIO) were used. For FH-conditioned analyses, all subjects without positive FH were set to unknown affection status. We used the HAPLOVIEW program 29 to estimate pairwise LD and to illustrate haplotype blocks. The haplotype blocks were partitioned by the confidence interval algorithm. 30 
Results

Association analyses of the ISHDSF sample
In single-marker association analyses, six of the 12 markers listed in Table 1 reached 5% significance level with at least one diagnostic definition. Of the six significant markers, four (rs3914025, rs3846726, rs3916441 and rs31400) are located between ACSL6 and IL3 genes. One marker, rs399714, is located in the ACSL6 gene and the other marker, rs2069803, is located on the 3 0 end of the IL3 gene. In addition, rs440970 approached significance at the 5% level. (Of note, the theoretical w 2 distribution P-values obtained for all single-marker tests were comparable with the permuted P-values, data not shown.) Of these markers, three (rs31400, rs31480 and rs2069803) are located in known IL3 promoters and enhancers. 8 Rs 40401, which changes the serine to proline at the 27th position of IL3 protein, was not significant. Of all markers typed, only rs31400 showed a significant deviation from HWE (P = 0.0099), with heterozygotes observed less than expected.
We carried out sliding window multimaker analyses. There were two regions (markers 2-5 and 7-11) that produced significant results in the ISHDSF sample. In the region covered by markers 2-5, the best associations were observed for marker combinations spanning LD blocks 1 and 2 (see Figure 1b) . For example, the P-values for the window for combination 3-4 were 0.0028, 0.0036 and 0.0154 for the narrow, intermediate and broad diagnoses, respectively. Here, the significant haplotype was protective. The major haplotype 1-1 or A-G was undertransmitted to affected subjects. For the region covered by markers 7-11, the strongest associations were observed for marker combinations spanning LD blocks 2 and 3. In this region, significant risk haplotypes were observed. Marker combination 8-9 (rs31400-rs31480) produced a global P-value of 0.0004 for the intermediate definition and the haplotype overtransmitted to the affected subjects was 2-1, or T-C, with P-values of 0.0088, 0.0060 and 0.0162 for the narrow, intermediate and broad definitions, respectively. By combining the information obtained from the sliding window analyses, the risk haplotype appeared to extend from markers 2 to 11. Other marker combinations that included markers 8 and 9 (rs31400 and rs31480) all produced significant P-values (see Table  2 ). Protective haplotypes were always more significant than the corresponding risk haplotypes.
Inspired by the identification of EREs -a signature of estrogen regulated genes -in the region, 7 we carried out sex-conditioned analyses. In the singlemarker analyses, we found that the significant markers were the same markers as those identified in the standard tests (compare Tables 1 and 3 ). The differences were that the results from sex-conditioned analyses were more significant. These results suggested that almost all association signals were derived from female offspring. Sex-conditioned analyses with the intermediate and broad definitions produced similar results, but the overall signals were weaker (data not shown). We also performed sex-conditioned analyses for multimaker haplotypes. As was observed in the single-marker analyses, the association signals were largely from the females as well (see Table 4 ). One exception was combination 5-6-7, where both males and females were significant. With this combination, the risk haplotype in the males was protective in the females and vice versa. This explained why we did not see any signals for this combination when both males and females were analyzed together (compare Tables 2 and 4 ).
Association analyses of the ICCSS and ITRIO samples
To verify the findings from the ISHDSF, we typed the same 12 SNPs in the ICCSS and ITRIO samples. For all markers typed, no HWE deviations were observed. In standard analyses with all subjects, we found no significant results. As the most important difference between the ISHDSF and the ICCSS and ITRIO was that ISHDSF had multiple affected individuals in each family, or FH with schizophrenia, we selected only those subjects with FH to perform the comparison. The results for single-marker analyses were summarized in Table 3 . Despite our power was only moderate owing to reduced sample sizes (there were 87 affected subjects with FH in ITRIO and 117 subjects with FH in the ICCSS), multiple markers reached or approached nominal significance in both the ICCSS and ITRIO samples. Like what was Interleukin 3 and schizophrenia X Chen et al observed in the ISHDSF, the associations were largely from females. Thus, we were able to confirm the sexspecific associations in all three samples. However, there were some discrepancies between the samples. We found that the transmitted alleles in ISHDSF and ITRIO were the same for all significant markers, but the transmitted alleles in the ISHDSF and ITRIO were underrepresented in the affected individuals in the ICCSS.
We also carried out haplotype analyses for those FH-positive subjects for both the ICCSS and ITRIO samples. In both the ICCSS and ITRIO, the associations were observed only in the females (see Table 4 ). The ITRIO produced exactly the same risk and protective haplotypes as that observed in the ISHDSF. While the individual P-values were much more significant in the ISHDSF than that in the ITRIO, the odds ratios of all implicated haplotypes were comparable between the samples. For the ICCSS sample, although the haplotypes implicated were the same as that observed in the ISHDSF and ITRIO, the risk haplotypes in the ICCSS were undertransmitted in both the ISHDSF and ITRIO.
LD structure analyses
To understand the association signals, we analyzed the haplotype structure and computed pairwise LD for the three samples. Figure 1 and Table 5 showed the pairwise LD (D 0 and r 2 , respectively) of the ISHDSF and ICCSS. The pairwise LD was very similar, and the LD block partitions were exactly same when all subjects were included. The ITRIO showed similar pairwise LD and same LD block partitions (data not shown). We also compared the subjects with and without FH from the ICCSS sample and again, the LD patterns were similar and LD blocks were the same (data not shown). Differences were also observed between the affected and unaffected subjects for both sexes when only subjects with FH were analyzed (Figure 1d-e) . Some pairwise LD (i.e. 2-3, 3-4, 3-11, 5-11, etc. in Figure 1d) were not statistically significant. We noticed that those markers showing different LD patterns in Figure 1d were the markers closest to the EREs (see Figure 1a) .
We reconstructed haplotypes for the 12 markers for all three samples using the MERLIN/FUGUE programs 31 and estimated their frequencies. In all three samples, the top six haplotypes were exactly the same and they accounted for 89, 91 and 94% of the haplotypes observed in the ISHDSF, ICCSS and ITRIO samples, respectively.
Discussion and conclusion
Chromosome 5q21-33 is a region likely to harbor risk genes for schizophrenia. We started fine-mapping this region several years ago and we found that a genomic interval from 130.5 to 131.5 million base pairs showed consistent associations in our ISHDSF sample. This interval contains several genes, including the ACSL6 and IL3. ACSL6 and IL3 are arranged in a head-to-head orientation. In the effort to exclude the IL3 from the list of candidate genes, we were surprised to find that several potentially functional SNPs in the promoter and enhancer of IL3 were associated with the disease (rs3914025, rs3846726, rs3916441, rs31400 and rs2069803) in the ISHDSF. Two-and three-marker haplotypes involving key SNPs (rs31400, rs31480 and rs2069803) were significant for all three disease definitions. When sexconditioned analyses were performed, we found that the associations -in both single markers and haplotypes -were largely derived from the female subjects. We followed up these findings with an independent case-control sample and a probandparents trio sample. We found the same sex-specific associations in those subjects with FH of schizophrenia in both samples. In LD and haplotype analyses, the three samples used in this study showed similar patterns. For those subjects with FH of schizophrenia, some differences of LD patterns were observed between the affected and unaffected females, and the markers involved were right next to the EREs.
From the genomic structure, we know that the interval between rs246999 and rs31480 can serve as promoters for both the ACSL6 and IL3 genes. This interval contains multiple transcription factor binding sites -AP-1, SP1 and GATA sites -that has been shown to regulate the expression of IL3 gene. 8 There are also multiple EREs identified recently in this region. 7 However, the regulating target of these EREs has not yet been identified. The physical positions of these EREs imply that they may be involved in the regulation of ACSL6 gene. There is also ample evidence that estrogen receptors have multiple pathways to regulate gene expression. These include the direct binding to EREs to activate transcription and indirect binding to AP-1, SP1 and GATA binding proteins to coactivate the expression of genes. 32, 33 In other words, estrogen can directly and indirectly regulate the expression of ACSL6 and IL3 genes. In one report, sex-specific expression of IL3 was found in breast cancer patients. 34 In another report, sexually dimorphic expression of both ACSL6 and IL3 was reported in a mouse model. 35 In addition, the key SNPs defining all risk haplotypes observed in all three samples are potentially functional. Rs31480 is only 16 bp upstream of the start codon and is within the 500 bp essential promoter sequence of the IL3 gene (for details of IL3 transcription regulation, see a recent review by Cockerill). 8 Rs31400 is located about 6.8 kb upstream of the first exon, which is between the two well-defined and well-studied IL3 enhancers located at 4.5 and14 kb upstream of the gene. 8 Another marker, rs2069803, which is also significantly associated with the disease in the family 36, 37 Despite all these information, we cannot exclude the possibility that these regulatory elements also regulate the expression of ACSL6 gene. Functional and expression studies are necessary to clarify this issue.
As seen in several other studies of schizophrenia candidate genes, different samples tend to have different risk haplotypes, [38] [39] [40] [41] [42] [43] [44] including flipping of the risk and protective haplotypes of DTNBP1 gene between the ISHDSF 45 and German nuclear families 46 and other samples. 47, 48 In this study, the two family samples identified the same risk and protective haplotypes, but in the case-control sample, the risk haplotype in the family samples become protective (underrepresented in the affected individuals). This raises a question of replication, that is, what constitutes a replication? In recent literature, it has been proposed that a replication can be made at the levels of individual markers, haplotypes and the gene. 49 In a meta-analysis of NRG1 gene, the authors seem to suggest that the replication at the level of gene is more robust. 50 Although both the ITRIO and ICCSS samples provide supporting evidence at the levels of individual markers, haplotypes and the gene as judged by the criteria proposed by Neale and Sham, 49 the conflict effect of alleles and haplotypes between the ICCSS and the family samples is puzzling. There may be several possible explanations to these conflict results. The obvious difference between ICCSS and ISHDSF and ITRIO is that ICCSS is a case-control design whereas the other two samples are familybased designs. It is possible, in theory, that some unknown stratifications are responsible for these results as the case-control study is more susceptible to this influence. Second, it is possible that the conflicting risk and protective haplotypes observed might be due to sampling fluctuation, given the relative small sample sizes for FH-positive subjects and the nominal significance in both the ITRIO and ICCSS samples. As the two family samples produce consistent results (i.e. the same alleles and haplotypes are overtransmitted to affected subjects), this is equivalent to one-tailed tests for the ITRIO sample. Based on this rationale, we incline to think that the signals from the ITRIO are more reliable. We should add that we performed 1000 permutation tests for all individual markers for both the ITRIO and ICCSS, the results were very similar to the theoretical w 2 distribution (data not shown). Ascertainment variation might be another factor potentially contributing to the conflicting risk haplotypes even when the probands were ascertained with same criteria. In addition, genotype errors, even at a relatively low level, might inflate type I error as indicated by a recent report. 51 For these reasons, further study with independent samples is necessary to clarify this issue.
In this study, we find that sex plays an important role in the association. In a recent, extensive review of worldwide incidence rate, it was found that males have significantly higher incidence rate than females. 52 The males have younger age of onset than the females. 53 Sex-specific associations with schizophrenia have been reported for the catechol omethyltransferase gene 38 and several other genes. 54, 55 It was also argued recently that sex may play a more important role in brain structure and psychiatric disorders than commonly acknowledged. [56] [57] [58] Our finding is consistent with this converging evidence. Furthermore, our finding of sex-specific associations in this region has strong genomic and molecular basis, that is, the existence of EREs and other coordinating transcription factor binding sites in this region and the report of sex-specific expression of IL3 and ACSL6 genes. 34, 35 We also find that FH is a contributing factor for the associations. Consistent associations are observed only in those subjects with a positive FH of schizophrenia. This is not the first time that FH has impacted so clearly on the association of a candidate gene. At least one prior study had shown a different pattern of association when FH was considered. 59 The immune system has long been hypothesized to be involved in schizophrenia. 60 IL3 is a major component of this system and plays a critical role in the development and differentiation of all hematopoietic cell types. Recently, it has been shown to have neurotropic activities in the brain. Transgenic mice with low levels of IL3 expression in the central nervous system demonstrate demyelination and motor disease. 10 Expression of antisense IL3 RNA in microglia causes progressive neurologic dysfunctions, including ataxia, bradykinesia and paralysis.
11 IL3 could potentially be involved in the pathophysiology of schizophrenia in several ways. First, IL3 is the upstream signal that activates the Akt1/Gsk3b apoptotic pathway. 61 Imbalance of apoptosis in the early stages of development of the central nervous system has been suggested as a cause of schizophrenia. 14, 62 Indeed, a higher Bax/Bcl-2 ratio, an index of apoptotic activation, is observed in schizophrenia patients. 63 In recent years, key components in this pathway, like the tumor necrosis factor, 64 Akt1 65 and Gsk3b, 66 have been implicated in schizophrenia. Second, IL3 is one of the major factors that activate the microglia in the brain. Activated microglia lead to inflammatory responses in the brain, 10, 12, 67 and some researchers have suggested that such inflammatory processes contribute to the etiology of schizophrenia. 68 For this reason, other inflammatory cytokines have been studied in schizophrenia. 69, 70 Clinical studies show that IL3 activity may be lower in schizophrenia patients. 17, 71 The nonsynonymous marker, rs40401, is reported to be associated with rheumatoid arthritis 72 that is negatively correlated with schizophrenia. 73 In summary, we present evidence that variants in and around IL3 are associated with schizophrenia in the ISHDSF, ICCSS and ITRIO samples. Specifically, the associations are sex-specific and depend on FH for schizophrenia. The sex-specific associations have a genomic and molecular basis. In all three samples, key SNPs in known regulatory elements of the IL3 gene underlie the risk haplotypes. They have the potential to directly change the expression of IL3. But we cannot rule out that the regulatory elements, especially the EREs in the shared promoter region also control the expression of ACSL6. In light of these findings, further study of these elements and SNPs and their effects on schizophrenia are warranted.
